Clin2
NCT06429930Worth exploringRecruiting

Safety study of L608 in healthy adults

Healthy Adult Participants

Part of Heart & circulation, Lungs & breathing clinical trials.

This trial tests an investigational medicine called L608 in healthy volunteers to check its safety and how the body processes it. It may help researchers understand the right dose for future studies.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
40 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You are between 18 and 65 years old.
  • Your body mass index (BMI) is between 18.5 and 32, and you weigh at least 110 pounds.
  • You are a non-smoker or you smoked fewer than 100 cigarettes in your life and quit at least 3 months ago.
  • If you are a woman who could become pregnant, you must not be pregnant or nursing, and you must use highly effective birth control during the study and for 3 months after.
  • You have no serious lung, heart, or bleeding conditions, and your blood pressure and lung function are within normal ranges.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06612970Recruiting· Phase 1
Single dose study of HB0056 in healthy adults

This trial tests a single dose of a new medicine called HB0056 in healthy volunteers to evaluate its safety and how the body processes it. If you are a healthy adult, you may help doctors understand if this drug is safe for future studies.

Christchurch
NCT07039669Recruiting· Phase 3
Study of 611 for moderate to severe COPD in adults

This trial tests a new medicine called 611 for people with moderate to severe COPD. It aims to see if adding 611 to your current treatments can help prevent flare-ups and improve symptoms.

Beijing, Beijing Municipality
NCT07644195Not yet recruiting· Phase 1
Testing an inhaled medication's safety in healthy people

This trial tests a new inhaled medication to see if it is safe and how it works in healthy volunteers. It may help with future lung conditions.

Lincoln, Nebraska
NCT07285655Recruiting· Phase 3
Study of L606 for lung disease with high blood pressure in the lungs

This trial tests a new treatment called L606 for people who have both a type of lung disease (ILD) and high blood pressure in the lungs (PH). The goal is to see if it is safe and helps with exercise and breathing.

Phoenix, Arizona
NCT07789899Recruiting· Phase 1
Safety study of a new investigational drug in healthy volunteers

This trial tests a new medicine to see how the body handles it and whether it is safe. It is for healthy people, not for treating a disease, and helps researchers decide if the drug can move to the next stage of testing.

Cambridge
NCT07510958Not yet recruiting· Phase 1
Testing a new inhaled drug for safety in healthy adults

This trial tests a new inhaler medication to see if it is safe and how the body processes it. It may help in future treatments for lung conditions.

Hear when a new Healthy Adult Participants trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.